Top compounds associated with response to SMYD1


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.029 0.4
mRNA BMS-754807 GDSC1000 pan-cancer AAC 0.028 0.4
mRNA BIX-01294 CTRPv2 pan-cancer AAC 0.029 0.4
mRNA Gemcitabine GDSC1000 pan-cancer AAC -0.029 0.4
mRNA VER-155008 CTRPv2 pan-cancer AAC 0.03 0.4
mRNA GDC-0941 gCSI pan-cancer AAC -0.055 0.4
mRNA oligomycin a CTRPv2 pan-cancer AAC -0.03 0.4
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC -0.031 0.4
mRNA GDC-0449 GDSC1000 pan-cancer AAC 0.029 0.4
mRNA BRD-A86708339 CTRPv2 pan-cancer AAC -0.041 0.4
Download CSV